Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

209
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

410
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
410
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

278
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
278
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

313
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Framework of Heart Failure with Preserved Ejection Fraction Management for Hospitalists: A Scoping Review.

Journal of Brown hospital medicine·2026
Same author

Incarceration and Health Care in the United States.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same author

Mindfulness: An Invisible Yet Integral Tool for Physicians.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same author

Goals of Care Discussions in Medical Training: Integrating Palliative Care for Holistic, Patient-Centered Care.

Healthcare (Basel, Switzerland)·2026
Same author

Simulation in Medical Education: History, Applications, and Effectiveness.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same author

PAPASH Syndrome: A Case Report and Lessons for Clinical Practice.

WMJ : official publication of the State Medical Society of Wisconsin·2026

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.1K

Evidence-Based Heart Failure Management: A Practical Guide for Hospitalists.

Jeffery Northway1, Farzana Hoque2

  • 1Saint Louis University School of Medicine, St. Louis, Missouri.

WMJ : Official Publication of the State Medical Society of Wisconsin
|January 7, 2026
PubMed
Summary

Heart failure management is evolving. Early, simultaneous pharmacologic therapy initiation is key for improving outcomes across all heart failure subtypes, including HFrEF, HFpEF, HFmrEF, and HFimpEF.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.1K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Heart failure (HF) presents a significant global health challenge with high morbidity and mortality.
  • Accurate classification of HF based on left ventricular ejection fraction (LVEF) is crucial for effective diagnosis and management.
  • Current classifications include heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF), heart failure with mildly reduced ejection fraction (HFmrEF), and heart failure with improved ejection fraction (HFimpEF).

Purpose of the Study:

  • To provide a comprehensive overview of current treatment strategies for different classifications of heart failure.
  • To highlight the importance of rapid pharmacologic therapy initiation in optimizing patient outcomes.
  • To address the challenges in managing HFmrEF and HFimpEF due to their heterogeneous nature.

Main Methods:

  • This narrative review synthesizes current evidence and guidelines.
  • It focuses on treatment strategies tailored to distinct HF classifications.
  • Emphasis is placed on the role of early and simultaneous initiation of key pharmacologic therapies.

Main Results:

  • While HFrEF management has seen therapeutic advancements, HFmrEF and HFimpEF require optimized, individualized treatment approaches.
  • Emerging strategies advocate for the prompt and concurrent introduction of foundational pharmacologic therapies across all HF subtypes.
  • Personalized treatment plans, informed by patient specifics and emerging data, are vital.

Conclusions:

  • Optimizing heart failure care necessitates a strategic approach to pharmacologic therapy initiation.
  • Tailoring treatments to specific HF classifications, particularly HFmrEF and HFimpEF, is essential for maximizing clinical benefits.
  • Rapid initiation of evidence-based therapies offers a promising avenue for improving patient outcomes in heart failure.